These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16863446)

  • 1. Tenofovir disoproxil fumarate for the treatment of HIV infection.
    Pham PA; Gallant JE
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):459-69. PubMed ID: 16863446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection.
    Gallant JE; Pham PA
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):415-22. PubMed ID: 15482138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
    Fung HB; Stone EA; Piacenti FJ
    Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet.
    Frampton JE; Croom KF
    Drugs; 2006; 66(11):1501-12; discussion 1513-4. PubMed ID: 16906786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.
    Lyseng-Williamson KA; Reynolds NA; Plosker GL
    Drugs; 2005; 65(3):413-32. PubMed ID: 15669881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
    Adusumilli S
    Drugs Today (Barc); 2009 Sep; 45(9):679-85. PubMed ID: 19956809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir disoproxil fumarate.
    Chapman T; McGavin J; Noble S
    Drugs; 2003; 63(15):1597-608. PubMed ID: 12887265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
    Kearney BP; Yale K; Shah J; Zhong L; Flaherty JF
    Clin Pharmacokinet; 2006; 45(11):1115-24. PubMed ID: 17048975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emtricitabine/tenofovir disoproxil fumarate.
    Drugs R D; 2004; 5(3):160-1. PubMed ID: 15139777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].
    Bernardino de la Serna JI; Mora Rillo M; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():7-12. PubMed ID: 19195432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.
    McColl DJ; Margot NA; Wulfsohn M; Coakley DF; Cheng AK; Miller MD
    J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1340-50. PubMed ID: 15483463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection.
    Deeks ED; Perry CM
    Drugs; 2010 Dec; 70(17):2315-38. PubMed ID: 21080746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate (Viread).
    Porche DJ
    J Assoc Nurses AIDS Care; 2002; 13(3):100-2. PubMed ID: 12064015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients.
    Droste JA; Kearney BP; Hekster YA; Burger DM
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):37-43. PubMed ID: 16340471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir disoproxil fumarate: in chronic hepatitis B.
    Perry CM; Simpson D
    Drugs; 2009 Nov; 69(16):2245-56. PubMed ID: 19852527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a significant drug interaction between raltegravir and tenofovir.
    Wenning LA; Friedman EJ; Kost JT; Breidinger SA; Stek JE; Lasseter KC; Gottesdiener KM; Chen J; Teppler H; Wagner JA; Stone JA; Iwamoto M
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3253-8. PubMed ID: 18625763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are all analogue combinations equal?].
    Miralles Alvarez C
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():38-44. PubMed ID: 19195437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Buti M; Homs M
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):413-21. PubMed ID: 22928893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conclusions. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():62-4. PubMed ID: 19195439
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with tenofovir disoproxil fumarate for antiretroviral therapy.
    Stephan C
    Expert Opin Pharmacother; 2008 May; 9(7):1197-209. PubMed ID: 18422476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.